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lar disease. Silent mating type information regulation 2 ho-
molog 1 Saccharomyces cerevisiae (SIRT1) is a nicotinamide 
adenine dinucleotide (NAD+)-dependent histone deacety-
lase that may also be involved in aging and diseases. SIRT1 
also deacetylates a number of nonhistone target proteins, 
including p53, endothelial nitric oxide synthase and fork-
head box protein. This review focuses on the latest scientific 
advances in understanding aging as well as delineates the 
possible therapeutic implications of p66 Shc and SIRT1 in this 
process.  Copyright © 2010 S. Karger AG, Basel 
 Aging is an inevitable part of life. Human life expec-
tancy has risen impressively over the last centuries due to 
significant improvements in hygiene and health care. 
Consequently, the proportion of aged people is steadily 
increasing. With aging, some physiological functions of 
organs are altered and resemble those occurring in dis-
ease conditions such as hypertension, chronic coronary 
disease and diabetes  [1] . Moreover, cardiovascular dis-
ease correlates with aging even in the absence of estab-
lished risk factors, suggesting that aging per se is an in-
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 Abstract 
 Due to improvements in lifestyle and healthcare, the propor-
tion of aged people is rising steadily, especially in developed 
countries. With aging, some physiological functions are al-
tered and resemble those occurring in disease conditions 
such as hypertension, chronic coronary disease and diabe-
tes. Thus, there is the urge to better understand molecular 
and cellular mechanisms underlying aging and aging-relat-
ed diseases. In rodents and possibly primates, calorie restric-
tion is an effective approach to extend lifespan by reducing 
free radical-induced damage. Increased production of oxy-
gen-derived free radicals plays an important role in the pro-
cess of aging. Reactive oxygen species are generated by dif-
ferent intracellular molecular pathways principally located in 
the cytoplasm and in the mitochondria. The mitochondrial 
protein p66 Shc is considered a longevity assurance gene 
since its genetic deletion extends the lifespan of rodents and 
displays protective effects in several models of cardiovascu-
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dependent risk factor for the development of cardio-
vascular disorders. Therefore, aging and aging-related 
diseases currently represent an important research topic.
 Calorie restriction is a widely used protocol for life 
span studies in experimental animals (rodents and pri-
mates)  [2] . It was first reported in 1935 that white rats fed 
with a low-calorie diet have an extended life span, lower 
body weight, lower heart weight and smaller bone size  [3] . 
However, there are still unanswered questions concern-
ing the global effects of calorie restriction. Indeed, as 
spontaneous cancer develops with aging in rodents, the 
real role of calorie restriction in animals is often confused 
with a reduction in the incidence of cancer, extension of 
life span, or both. Moreover, it is not fully understood 
whether the beneficial effects of calorie restriction also 
extend to humans; however, if they do, the underlying 
mechanisms have yet to be elucidated.
 Interestingly, in a 20-year longitudinal adult-onset 
calorie restriction study in rhesus monkeys, 30% calorie 
restriction significantly reduces aging-related deaths  [4] . 
Monkeys in the calorie-restricted group conserved glu-
cose homeostasis, indicating a beneficial effect of calorie 
restriction on diabetes. The incidence of cancer increases 
with aging in rhesus monkeys, confirming the spontane-
ous development of cancer in aged rodents and indicating 
that cancer is an aging-related disease as well. However, 
monkeys under calorie restriction have a lower incidence 
of cancer compared with control animals. Calorie restric-
tion also reduces the incidence of cardiovascular diseases 
in the same group. In addition, aged monkeys have been 
shown to develop brain atrophy in the bilateral frontal 
and temporal cortex in both control and diet-treated 
groups, suggesting a pathophysiological change observed 
with aging which is independent of calorie intake. How-
ever, monkeys on a low-calorie diet maintain grey matter 
volume in subcortical regions  [4] , supporting the finding 
that calorie restriction preserves locomotory activity in 
aged monkeys  [5] . These results underscore the beneficial 
effects of calorie restriction on aging and aging-related 
diseases in primates.
 In humans, Okinawan populations consuming 20% 
less calories compared to the average caloric consump-
tion of the Japanese population display reduced mortal-
ity in elderly people and also decreased death rates of 
30–40% due to lower incidences of cancer, cerebrovascu-
lar and heart diseases. Furthermore, Okinawans who 
switch to a Western diet are shown to have similar mor-
tality and morbidity as people from Western countries. 
These data confirm the beneficial effects of calorie re-
striction in humans, although it cannot be excluded that 
a normal diet may adversely affect longevity indepen-
dently of its caloric content. Strikingly, the data from 
members of the Calorie Restriction Society show consis-
tent and positive effects of calorie restriction in adults. 
Compared with subjects on normal Western diets, sub-
jects on a low-calorie diet have less risk factors for ath-
erosclerosis, including reduced body mass index and 
blood pressure (both systolic and diastolic), lower levels 
of glucose, insulin, tumor necrosis factor-  and C-reac-
tive protein, decreased levels of triglycerides and low-
density lipoprotein (LDL)-cholesterol, and higher levels 
of high-density lipoprotein (HDL)-cholesterol. These 
beneficial effects are shown  after one year of caloric re-
striction and improve further after six years of restric-
tion  [6] . Likewise, a Mediterranean diet characterized by 
large quantities of olive oil also has protective effects on 
cardiovascular risk factors  [7] .
 The Free Radical Theory of Aging 
 The free radical theory of aging was first proposed by 
Denham Harman in the 1950s and states that production 
of reactive oxygen species (ROS), occurring as part of 
normal cellular metabolism, increases with aging and 
further contributes to the process of aging. Hydroxyl rad-
icals and hydrogen peroxide (H 2 O 2 ) are considered to 
play an important role in the process of aging  [8] . How-
ever, the exact source of increased ROS observed in aging 
is still unclear. Mitochondria are one of main sources of 
intracellular superoxide anion radical (O2–) and H 2 O 2 , 
thus they are thought to experience heavy oxidative dam-
age with aging. The life-time exposure of mitochondria 
to ROS damage in turn enhances ROS production, which 
ultimately and negatively affects life span. Enhanced pro-
duction of ROS in aging is also associated with upregu-
lated expression of inducible nitric oxide synthase, and 
nicotinamide adenine dinucleotide phosphate-oxidase 
and/or downregulation of antioxidants, such as extracel-
lular superoxide dismutase, glutathione peroxide and de-
creased catalase activity  [9] .
 The increased production of ROS observed with aging 
contributes to oxidizing lipids, consequently modifying 
membrane lipid composition and reducing its fluidity. 
The mitochondrial membrane is particularly susceptible 
to peroxidation because of its high composition of un-
saturated lipids. Aging and aging-related ROS produc-
tion increase mitochondrial membrane rigidity and 
 further reduce efficiency of mitochondrial oxidative 
phosphorylation, resulting in cell apoptosis  [10] . Calorie 
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restriction and a Mediterranean-style diet maintain nor-
mal membrane composition by reducing the index of un-
saturation/saturation of lipids, thus blunting ROS-medi-
ated damage of cell membranes  [11] .
 Protein carbonyl, a protein oxidation marker, has been 
shown to increase with aging in the mouse brain and 
skeletal muscle mitochondria  [12] . However, data con-
cerning the effect of calorie restriction on protein car-
bonyl content are not consistent. Indeed, mitochondrial 
carbonyl concentration was not significantly changed in 
mice under calorie restriction  [13] .
 Aging-related ROS also damage mitochondrial DNA 
(mtDNA) as confirmed by the elevated frequency of dele-
tion occurring in mtDNA. An increased level of deletion 
frequency of mtDNA is observed in the brain, liver, heart 
and skeletal muscle of old rats and a calorie restriction 
diet decreases the higher level of deletion frequency in 
liver of aged mice  [14] . Hydroxytyrosol, an important 
polyphenolic compound in olive oil, stimulates mito-
chondrial transcription factor A and increases the 
amount of mitochondria inside of cells, therefore main-
taining mitochondrial functions  [15] .
 The Effect of Calorie Restriction on ROS Generation 
 It is generally believed that the effect of calorie restric-
tion on life span is due to a reduced metabolic rate and a 
decreased mitochondrial oxygen consumption. Never-
theless, pigeons have a comparable metabolic rate and 
body mass to rats, but have an eightfold longer life span. 
More importantly, the rate of H 2 O 2 generation in mito-
chondria is lower in long-lived rather than short-lived 
animals. Thus, it is logical to correlate the rate of aging 
and maximum longevity to the rate of mitochondrial 
ROS generation  [16] .
 In mitochondria, aging-related ROS production is 
mainly due to reduced activity of mitochondrial electron 
chain complexes  [17] . The activity of the four electron 
transport systems is decreased with aging in human as 
well as in rodent skeletal muscles. Calorie restriction 
maintains the activity of the four electron complexes, 
thus reducing ROS production in mitochondria  [17] . In 
addition, calorie restriction has a direct effect on anti-
oxidant enzymes. In rat liver, calorie restriction is shown 
to restore catalase and glutathione peroxidase activity, as 
well as upregulating the expression of Cu-Zn superoxide 
dismutase  [18] . It is also reported that calorie restriction 
prevents the decrease of glutathione and glutathione 
transferase activity in rat skeletal muscle  [19] .
 On the whole, calorie restriction reduces the genera-
tion of free radicals due to attenuation of mitochondrial 
damage and upregulation of defense enzymes. Strict con-
trol of calorie intake is, however, an unpleasant and tough 
experience. Severe long-term restriction could induce 
malnutrition, especially in aged people. Meanwhile, in 
large prospective clinical trials, neither the separate nor 
the combined antioxidant treatment with vitamins C and 
E significantly reduced the incidence of major adverse 
cardiovascular events. This could be explained by several 
factors: (1) natural antioxidants are commonly found in 
normal human daily diet and, thus, supplements may 
have no additional effects; (2) additional antioxidant 
treatment may depress endogenous antioxidant defense 
systems, thus preventing the expected positive effects of 
antioxidant therapy; and (3) the intracellular pathway 
may be sequestered in organelles (for instance mitochon-
dria) and antioxidants are not reachable for the com-
pound. Therefore, there is a call for new therapeutics oth-
er than dieting and antioxidant treatment to prolong life 
span and to improve life quality.
 Mammalian Longevity Assurance Gene Sirtuins 
 Silent mating type information regulation 2 homolog 
(Sir2) family proteins, sirtuins, are considered to be cru-
cial regulators of life span extension in the setting of cal-
orie restriction. Calorie restriction activates Sir2 protein 
in yeast  Saccharomyces cerevisiae and flies. SIRT1, the 
mammalian Sir2, is consistently upregulated in mice un-
der calorie restriction. SIRT1 protein is a nicotinamide 
adenine dinucleotide (NAD+)-dependent histone de-
ace tylase, which also deacetylates a number of nonhis-
tone target protein, including tumor suppressor p53 pro-
tein, members of the forkhead transcription factor fam-
ily (FoxO), stress response proteins Ku70 and nuclear 
factor   -light-chain-enhancer of activated B cells, and 
metabolic regulator   -subunit of the G protein (PCG-1  ) 
 [20, 21] . Starvation enhances the expression of SIRT1 
protein in mouse liver and in human peripheral blood 
mononuclear cells, which returns to a normal level upon 
feeding  [22] , indicating that SIRT1 is sensitive to nutri-
tion and metabolic changes. The upregulated SIRT1 pro-
tein deacetylates PGC-1  , a transcriptional coactivator 
that controls energy state in a NAD+-dependent manner 
in hepatic cells from both vivo and vitro experiments, 
suggesting a regulatory role of SIRT1 in mitochondrial 
biogenesis and energy metabolism  [22] . Thus, SIRT1 is 
an important mediator of the beneficial effects observed 
 Camici  /Shi  /Cosentino  /Francia  /Lüscher  Gerontology 2011;57:101–108104
with calorie restriction, and is probably involved in life 
span control.
 The presence of SIRT1 protein is also observed in pan-
creatic   -cells  [23] . In cell culture experiments, inhibi-
tion of SIRT1 reduces insulin secretion, suggesting a role 
of SIRT1 in insulin secretion  [23] . In the aorta of strepto-
zotocin-induced type I diabetes mice, the expression of 
SIRT1 protein is reduced while acetylated p53 and p21 
proteins are upregulated  [24] . Resveratrol, a small-mole-
cule activator of SIRT1, deacetylates p53 and p21 in the 
aorta, thereby improving endothelial dysfunction by 
downregulating intercellular adhesion molecule-1 ex-
pression and inhibiting leukocyte rolling, which suggests 
a protective role for SIRT1 in diabetes-induced vascular 
dysfunction  [24] . In type II diabetes mice, genetic upreg-
ulation of SIRT1  [24] or treatment with resveratrol  [25] 
consistently enhances insulin secretion and improves 
glucose tolerance. These data suggest that modulation of 
SIRT1 expression and/or activity would be of therapeutic 
interest against diabetes and diabetes-related cardiovas-
cular complications.
 SIRT1 also has beneficial effects on endothelial cells. 
In rat aorta, inhibition of SIRT1 ex vivo causes an im-
paired endothelium-dependent and nitric oxide (NO)-
mediated relaxation. Restoration of SIRT1 increases en-
dothelial nitric oxide synthase (eNOS) expression by 
deacetylation of both lysine 496 and 506, indicating that 
SIRT1 directly regulates eNOS  [26] . In apoE –/– mice fed 
on a high-fat diet, mice overexpressing endothelial cell-
specific SIRT1 display blunted atherosclerosis due to an 
enhanced eNOS expression and preserved endothelium-
dependent relaxation of the aorta, indicating a beneficial 
effect of SIRT1 as well as eNOS on atherogenesis  [27] . 
Furthermore,  NO   donor   increases   SIRT1   expression 
and delays cell senescence in human endothelial cells. 
Calorie restriction fails to enhance SIRT1 expression in 
eNOS –/– mice  [28] , suggesting that NO may also directly 
modulate SIRT1 expression. This result confirms a pro-
tective role of SIRT1 and eNOS for the development of 
atherosclerosis.
 In transgenic mice with heart-specific overexpression 
of SIRT1, beneficial effects are observed only in animals 
with a slight or moderate upregulation of SIRT1 mediated 
by an increased catalase expression through the FoxO-
dependent signaling pathway. Furthermore, heart-spe-
cific overexpression of SIRT1 retards aging of the heart 
and protects the heart from paraquat-induced oxidative 
stress  [29] .
 Mammalian Longevity Assurance Gene p66 Shc 
 Shc protein is considered to be a regulator of longevity 
in mammals  [30] . The mammalian Shc adaptor protein 
has three isoforms of 46, 52 and 66 kDa (p46 Shc , p52 Shc , 
and p66 Shc ). p66 Shc is the only isoform to play an impor-
tant role as a redox enzyme implicated in mitochondrial 
ROS generation and translation of oxidative signals into 
apoptosis. Genetic deletion of p66 Shc in the mouse leads 
to an extended life span which is correlated with a re-
duced production of intracellular oxidants and a de-
creased level of mtDNA content  [9, 30] . p66 Shc predomi-
nantly localizes in the cytoplasm, with a small fraction 
(10–40%) in the mitochondria. Ultraviolet light irradia-
tion as well as oxidants such as H 2 O 2 phosphorylate 
p66 Shc on serine 36, which in turn induces translocation 
of p66 Shc to the mitochondria  [31] . Activated p66 Shc in-
creases mitochondrial Ca2+ sensitivity and thus interacts 
with reduced cytochrome c to increase the production of 
H 2 O 2 which promotes the opening of the mitochondrial 
permeability transition pore and leads to apoptosis  [31] . 
p66 Shc is also involved in H 2 O 2 -induced forkhead inhibi-
tion by increasing the phosphorylation of forkhead (Dro-
sophila) homolog (rhabdomyosarcoma) like 1 (FKHRL1, 
also known as FoxO3a)  [32] . Furthermore, according to 
cell type and stimulation, this ROS-sensitive protein 
plays an important role in regulating apoptosis by both 
p53-dependent and p53-independent mechanisms. In 
light of its pivotal role in ROS generation, many efforts 
have been made to investigate the pathophysiological role 
of p66 Shc in aging and aging-related ROS-mediated dis-
eases ( fig. 1 )  [33] .
 It is reported that p66 Shc is highly expressed in fibro-
blasts from centenarians and in peripheral blood mono-
cytes from diabetic patients. In line with the above, it is 
widely accepted that p66 Shc is linked to aging and/or ROS-
related diseases in humans. Genetic deletion is a useful 
tool to study the role of p66 Shc protein under pathophysi-
ological conditions since identical Shc genomic organiza-
tion, transcript assembly and a high degree of amino acid 
identity have been reported in mice and humans  [33] .
 In line with this hypothesis, p66 Shc–/– mice are pro-
tected from aging-dependent endothelial dysfunction 
 [34] . Wild-type mice display aging-dependent loss of 
NO-mediated vasorelaxation, while p66 Shc–/– mice show 
a maintained ability to relax by virtue of an increased NO 
bioavailability, lower aortic O2– levels and reduced aortic 
3-nitrotyrosine content ( fig. 2 ). In endothelial cell culture 
experiments, inhibition of p66 Shc increases NO produc-
tion by phosphorylating eNOS on serine 1177  [35] . There-
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 Fig. 1. Schematic representation of the endothelium and some of 
its key derived vasoactive substances. p66 Shc is principally located 
in the mitochondria, where it contributes to the production of su-
peroxide anion (O2–), radicals which scavenge NO to form per-
oxynitrite (ONOO – ). Different stress stimuli (e.g. glucose, oxLDL, 
hypertension, shear stress) increase in number and occurrence 
with age and enhance the production of O2–, thus exacerbating en-
dothelial dysfunction. oxLDL = Oxidized low-density lipopro-
tein; ET-1 = endothelin-1; NOS = NO synthase; ONOO = per-
oxynitrite; MCP-1 = monocyte chemotactic protein-1; ICAM = 
intercellular adhesion molecule; VCAM = vascular cells adhesion 
molecule; NF  B = nuclear factor-kappa B; I  B = inhibitor to 
NFB; NADPH = nicotinamide adenine dinucleotide phosphate-
oxidase; PKC1 = protein kinase C-1; GPx = glutathione peroxidase 
 [33] . 
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 Fig. 2.  a Age-dependent changes in endothelium-dependent re-
laxation of wild-type (WT) and p66 Shc–/– aortas. Line graphs show 
concentration-response curves to acetylcholine. Results are pre-
sented as means  8 SEM; n = 7 in each group.  b Bar graph showing 
peak concentrations of NO in young (gray bars) and old (black 
bars) WT and p66 Shc–/– mice, respectively. Results are presented 
as means  8 SEM; n = 4 to 6 in each group.  *  p  ! 0.05 vs. young 
WT  [34] . 
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 Fig. 4. Schematic representation of effects of p66 Shc and SIRT1 in 
anti-aging treatments. The production of ROS increase with 
 aging. p66 Shc activates eNOS by phosphorylation while SIRT1 
maintains eNOS protein by deacetylation. ROS-induced apopto-
sis goes through FoxO3 or the p53 pathway. Oxidative stress acti-
vates FoxO3 by a combination of acetylation and phosphorylation 
events. p66 Shc mediates in H 2 O 2 -induced phosphorylation, where-
as SIRT1 directly deacetylates effect on FoxO3. p66 Shc is a down-
streaming transcriptional target of p53, while SIRT1 negatively 
regulates the ability of p53 by protein deacetylation. 
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fore, p66 Shc adaptor protein is regarded as a key player in 
aging-dependent loss of endothelial integrity and NO 
bioavailability.
 Furthermore, p66 Shc–/– apoE –/– mice fed with a high-
fat diet display lower levels of lipid peroxidation com-
pared to control mice, thus suggesting a possible role of 
p66 Shc in the oxidative modification of lipoprotein. Com-
pared with control littermates fed high-fat diets, p66 Shc–/– 
apoE –/– mice are shown to have less aortic lesion forma-
tion accompanied by a decrease in intimal foam cell for-
mation and lower levels of systemic plasma isoprostanes 
 [36] . Additional studies confirm a tight link between 
plasma levels of LDL-cholesterol and p66 Shc in pacemak-
er-implanted patients, thus underscoring that p66 Shc 
plays a role in translating the effects of different aging-
related risk factors into arterial dysfunction and early 
atherosclerotic lesion  [33] .
 High glucose induces a cascade of cellular events 
which increase the production of free radicals, thus de-
creasing NO bioavailability and eventually leading to 
vascular dysfunction. In conditions of raised glucose 
plasma levels, p66 Shc is known to oxidize cytochrome c 
and, in turn, generate proapoptotic ROS through a pro-
tein kinase c-  dependent pathway  [31] . In line with the 
above, p66 Shc protein expression is increased in aortas of 
type I diabetes mice  [37] . p66 Shc–/– mice have comparable 
glucose levels as control mice  [37, 38] , indicating that 
knocking out p66 shc protein does not alter glycemic lev-
els. However, they are protected from diabetic glomer-
ulopathy as demonstrated by reduced glomerular cell 
apoptosis and decreased extracellular matrix deposition, 
indicating the pivotal role of p66 Shc in translating ROS-
mediated insults into apoptosis  [38] . Furthermore, strep-
tozotocin-induced diabetic p66 Shc–/– mice are protected 
against endothelial dysfunction via a blunted ROS pro-
duction and the consequently preserved NO bioavailabil-
ity ( fig. 3 ). This finding reinforces the concept of a causal 
relationship between high glucose, ROS, p66 Shc and vas-
cular dysfunction  [37] .
 Notably, a definite balance between ROS damage and 
endothelial progenitor cell (EPC)-mediated repair exists 
and guarantees endothelial integrity. In keeping with this 
theory, the increased ROS production observed in aged 
mice or mice with a pathophysiological condition, such 
as hyperglycemia, could explain both impairment of 
 endothelial function and loss of EPC-mediated repair, 
which ultimately leads to vascular dysfunction  [39] . 
These changes, however, are not observed in p66 Shc 
knockout mice which present lower levels of ROS and a 
preserved endothelial function. Therefore, the mitochon-
drial adaptor protein p66 Shc represents a promising target 
protein for slowing the process of aging and blunting ag-
ing-related ROS generation  [33] .
 Clinical Perspectives and Conclusions 
 The signaling pathways relevant to aging discussed 
here are currently under intensive investigation as poten-
tial targets for new anti-aging treatments based either on 
reducing oxidative damage or enhancing cell defenses. 
Indeed, p66 Shc and SIRT1 share multiple molecular tar-
gets ( fig. 4 ). First, both proteins enhance NO bioavailabil-
ity through eNOS upregulation/activation and/or reduc-
tion of NO scavenging. Indeed, p66 Shc activates eNOS by 
phosphorylating serine 1177  [35] , while SIRT1 regulates 
eNOS activity by deacetylation on both lysine 496 and 
506  [26] . Second, upregulation of FoxO3, which is impor-
tant for increasing activity of antioxidant systems such as 
catalase and superoxide dismutases, is mediated by both 
p66 Shc and SIRT1 through phosphorylation and acetyla-
tion, respectively. In fact, p66Shc plays a role in H 2 O 2 -
induced phosphorylation of FoxO3  [32] , whereas SIRT1 
has a direct effect on deacetylation of FoxO3  [20] . Third, 
p66Shc is a downstream target of p53  [30] , whereas SIRT1 
negatively regulates p53 by protein deacetylation  [24] .
 It may seem optimistic to assume that simply down-
regulating p66 Shc , upregulating SIRT1, or a combination 
of the two will effectively slow down aging in humans and 
shift the pathophysiological imbalance towards a nor-
malized condition. SIRT1 exerts multiple protective ef-
fects. Nevertheless, physical training is reported to re-
store SIRT1 protein in both heart and adipose tissue of 
aged mice, supporting previous evidence showing benefi-
cial effects of exercise training  [40] . Furthermore, res-
veratrol, one of the polyphenolic compounds in grapes 
and wine, is reported to be a small-molecule activator of 
SIRT1  [21, 25] , which may be worth investigating as a po-
tential treatment for aging-related human diseases. p66 Shc 
is a mitochondrial protein mediating oxidative stress  [9, 
33] . Genetic deletion of p66Shc protein has shown mul-
tiple beneficial effects in the process of atherosclerosis 
and diabetes in experimental animal models. Therefore, 
it is believed that the inhibition of p66Shc is the more at-
tractive therapeutic option to reduce oxidative stress in 
human rather than antioxidant treatment as previously 
discussed  [33] . The target proteins described in this re-
view may offer new insights to better characterize under-
lying mechanisms of aging and may potentially represent 
novel therapeutic targets to prevent aging-related disease. 
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